fycompa 6 mg
orifarm as - perampanel - tablett, filmdrasjert - 6 mg
cardizem retard 90 mg
pfizer as - diltiazemhydroklorid - depottablett - 90 mg
cardizem retard 120 mg
pfizer as - diltiazemhydroklorid - depottablett - 120 mg
cardizem retard 180 mg
pfizer as - diltiazemhydroklorid - depottablett - 180 mg
cardizem uno 180 mg
pfizer as - diltiazemhydroklorid - depottablett - 180 mg
cardizem uno 240 mg
pfizer as - diltiazemhydroklorid - depottablett - 240 mg
cardizem uno 300 mg
pfizer as - diltiazemhydroklorid - depottablett - 300 mg
leqvio
novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modifiserende midler - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
fycompa
eisai gmbh - perampanel - epilepsier, delvis - antiepileptics, , andre antiepileptics - fycompa er indisert for tilleggsbehandling av partielle anfall med eller uten sekundært generaliserte anfall hos voksne og ungdommer fra 12 år med epilepsi. fycompa er indikert for adjuvant behandling av primær generell tonic-clonic beslag i voksne og unge pasienter fra 12 år med idiopatisk generalisert epilepsi.
fycompa 4 mg
paranova as - perampanel - tablett, filmdrasjert - 4 mg